Catalyst Pharmaceuticals
CPRX
#3529
Rank
NZ$7.04 B
Marketcap
NZ$57.56
Share price
0.00%
Change (1 day)
58.64%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2026 (TTM): NZ$3.09

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$3.31. In 2025 the company made an earnings per share (EPS) of NZ$3.22 an increase over its 2024 EPS that were of NZ$2.54.

EPS history for Catalyst Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$3.09-3.85%
2025NZ$3.2226.62%
2024NZ$2.54
2022NZ$1.46110.53%
2021NZ$0.69-47.22%
2020NZ$1.32132.26%
2019NZ$0.57-191.18%
2018NZ-$0.6254.55%
2017NZ-$0.40-4.35%
2016NZ-$0.42-8%
2015NZ-$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 269.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.30-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.94 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ-$4.81-245.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ-$91.97-2,879.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-104.97%๐Ÿ‡บ๐Ÿ‡ธ USA